bluebird up big after Q1 report

Shares of bluebird bio (BLUE +27.9%) pop on a 5x surge in volume in response to its Q1 report after yesterday's close.

Revenue: $6.3M (+473%); operating loss: ($10.7M) (-64.6%); net loss/share: ($0.44) vs ($19.94); cash & equiv: $192.5M (-6.7%); cash burn: ($11.9M).

153 mutual funds have positions, up from 73 a year earlier.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs